Infection Prevention and Control of Carbapenem-resistant Enterobacteriaceae (CRE) in Western Australian Healthcare Facilities

Applicable to: All healthcare workers employed in WA public and private healthcare facilities, including All healthcare workers employed in WA public and private healthcare facilities, including mental health and residential care facilities.

Description: This operational directive describes the minimum requirements for the routine screening and the subsequent management of patients identified with Carbapenem-resistant Enterobacteriaceae (CRE) in WA healthcare facilities (HCFs).

Infection Prevention and Control of Carbapenem-resistant Enterobacteriaceae (CRE) in Western Australian Healthcare Facilities

Compliance with this Operational Directive is mandatory for all public hospitals and those private healthcare facilities, including satellite haemodialysis units, contracted to provide services to public patients.

This Operational Directive describes the minimum requirements for the routine screening and subsequent management of patients identified with carbapenemase–resistant Enterobacteriaceae (CRE) in Western Australian (WA) healthcare facilities (HCFs).  All acute care HCFs shall ensure their procedures are aligned with those described in the attached document Infection Prevention and Control of Carbapenem–resistant Enterobacteriaceae (CRE) in Western Australian Healthcare Facilities.  Guidance for the management of CRE‑positive patients in residential care facilities (RCFs) is also provided, with the expectation that WA RCFs will comply with the precautions described in the Guidelines.


Dr David Russell-Weisz
A/DIRECTOR GENERAL
DEPARTMENT OF HEALTH WA

Date of effect: 22 October 2017 to 22 October 2017

Policy Framework

Related documents